Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Science (New York, N.Y.)|September 25, 2025
What if NIH had been 40% smaller?Pierre Azoulay, Matthew Clancy, Danielle Li, et al.Science (New York, N.Y.)|April 1, 2017
The applied value of public investments in biomedical researchDanielle Li, Pierre Azoulay, Bhaven N SampatThe Review of Economic Studies|October 31, 2019
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding RulesPierre Azoulay, Danielle Li, Joshua S Graff Zivin, et al.The New England Journal of Medicine|November 16, 2007
The anatomy of medical school patentingPierre Azoulay, Ryan Michigan, Bhaven N SampatThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 10, 2021
The Government and Pharmaceutical Innovation: Looking Back and Looking AheadBhaven N SampatThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
<b>Doubling Down:</b> Will Large Increases in the NIH Budget Promote More Meaningful Medical Innovation?Bhaven N SampatAmerican Journal of Public Health|November 15, 2008
Academic patents and access to medicines in developing countriesBhaven N SampatAmerican Journal of Public Health|February 19, 2016
Corporate Funding for Schools of Public Health: Confronting the Ethical and Economic ChallengesRonald Bayer, Bhaven N SampatJournal of Health Politics, Policy and Law|May 7, 2013
How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?Bhaven N Sampat, Tahir AminHealth Affairs (Project Hope)|February 4, 2011
What are the respective roles of the public and private sectors in pharmaceutical innovation?Bhaven N Sampat, Frank R LichtenbergPageof 4